Novartis CEO: Tariffs are an overhang on the pharmaceutical sector

4 hours ago 1
Young female scientist working in laboratory

Solskin

Novartis (NYSE:NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.

During a CNBC interview, Narasimhan emphasized the company’s strong fundamentals, pointing to 10 consecutive quarters of raised guidance and

Recommended For You

More Trending News

Read Entire Article